Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Steven D. Flanagan is active.

Publication


Featured researches published by Steven D. Flanagan.


Drug and Alcohol Dependence | 1994

The dopamine D2 receptor gene: a genetic risk factor in substance abuse

David E. Comings; Donn Muhleman; Chul Ahn; Reinhard Gysin; Steven D. Flanagan

Drug abuse has grown to epidemic proportions. Dopaminergic reward pathways have frequently been implicated in the etiology of drug addiction. To examine the possible role of genetic variants of the dopamine D2 (DRD2) gene in susceptibility to drug abuse we determined the prevalence of the TaqI A1 variant of the DRD2 gene in 200 white patients hospitalized in the Addiction Treatment Unit of a Veterans Administration Hospital. While the prevalence of the D2A1 allele was not significantly increased over controls, it did increase from 21% in subjects with alcohol abuse only to 32% in subjects with alcohol dependence only, consistent with other studies showing an association with the severity of alcoholism. By contrast, of 104 subjects with a discharge diagnosis of drug and alcohol abuse/dependence, 42.3% carried the D2A1 allele versus 29.0% of the 763 white controls (representing all white controls published to date) (P = 0.006). Of those who spent more than


Journal of Liquid Chromatography & Related Technologies | 1984

Toroidal coil countercurrent chromatography in the affinity partitioning of nicotinic cholinergic receptor enriched membranes

Steven D. Flanagan; Göte Johansson; Beverly Yost; Yoichiro Ito; Ian A. Sutherland

25/week on two or more substances, 56.9% carried the D2A1 allele versus 28.2% of those abusing a single substance (P < 0.0005). Multiple logistic regression analysis showed a highly significant association between multiple substance abuse based on money spent and the presence of the D2A1 allele (P = 0.0003) and age of onset of abuse (P < 0.0001). D2A1 carriers exceeded D2A2A2 subjects for a history of being expelled from school for fighting (P = 0.001), and of those ever jailed for violent crimes, 53.1% carried the D2A1 allele versus 28.8% of those jailed for non-violent crimes (P = 0.011).(ABSTRACT TRUNCATED AT 250 WORDS)


Annals of Neurology | 1995

Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives

Lindsay A. Farrer; L. Adrienne Cupples; Cornelia M. van Duijn; Alexander Kurz; Reinhilde Zimmer; Ulrich Müller; Robert C. Green; Valerie Clarke; John M. Shoffner; Douglas C. Wallace; Helena C. Chui; Steven D. Flanagan; Ranjan Duara; Peter St George-Hyslop; Sanford A. Auerbach; Ladislav Volicer; John M. Wells; Christine Van Broeckhoven; John H. Growdon; Jonathan L. Haines

Abstract A variation on the aqueous polymer phase partition method, affinity partitioning, has proved suitable for the preparative scale purification of binding site enriched membrane fragments. The full resolving potential of the affinity partitioning technique often requires the utilization of multiple extraction procedures such as countercurrent distribution. In this report, we evaluate the combination of a newly developed countercurrent purification technique, toroidal coil chromatography, with affinity partitioning. This approach provides an efficient method for purification and characterization of membrane bound nicotinic cholinergic receptors. The relative merits of the toroidal coil chromatography technology and the more conventional thin-layer countercurrent distribution techniques are compared.


Genetic Testing | 1997

An allelic variant at the ATM locus is implicated in breast cancer susceptibility.

Garry P. Larson; Guoxiang Zhang; Shaofeng Ding; Kimberly Foldenauer; Nitin Udar; Richard A. Gatti; Donna Neuberg; Kathryn L. Lunetta; John C. Ruckdeschel; Jeffrey Longmate; Steven D. Flanagan; Theodore G. Krontiris


Nucleic Acids Research | 2001

PCR candidate region mismatch scanning: adaptation to quantitative, high-throughput genotyping

Martin Beaulieu; Garry P. Larson; Louis Geller; Steven D. Flanagan; Theodore G. Krontiris


Biochemistry | 1983

Immunochemical and molecular differentiation of 43 000 molecular weight proteins associated with Torpedo neuroelectrocyte synapses.

Reinhard Gysin; Beverly Yost; Steven D. Flanagan


Archive | 2001

Candidate region mismatch scanning for genotyping and mutation detection

Theodore G. Krontiris; Martin Beaulieu; Steven D. Flanagan


Drug and Alcohol Dependence | 1993

Dopamine D2 receptor gene Taq I ‘A’ locus map including ‘A4’ variant: relevance for alcoholism and drug abuse

Antonio M. Persico; Bruce F. O'Hara; S. Farmer; Reinhard Gysin; Steven D. Flanagan; George R. Uhl


Biochemistry | 1986

Creatine kinase isoenzymes in Torpedo californica: absence of the major brain isoenzyme from nicotinic acetylcholine receptor membranes

Reinhard Gysin; Beverly Yost; Steven D. Flanagan


Archive | 1998

Disease association by locus stratification

Theodore G. Krontiris; Steven D. Flanagan; Garry P. Larson

Collaboration


Dive into the Steven D. Flanagan's collaboration.

Top Co-Authors

Avatar

Theodore G. Krontiris

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar

Garry P. Larson

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar

Reinhard Gysin

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar

Beverly Yost

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar

Martin Beaulieu

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar

Louis Geller

City of Hope National Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Antonio M. Persico

National Institute on Drug Abuse

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge